Melanoma/Skin Cancer

Top Story

American Academy of Dermatology updates guidelines for primary cutaneous melanoma

January 11, 2019

Roswell Park immunotherapy expert honored for melanoma research

January 11, 2019
Igor Puzanov, MD, MSCI, FACP, received the Melanoma Foundation Award for outstanding and lifelong

‘Cancer-agnostic’ NTRK inhibitor approval ushers in paradigm of personalized genomics-guided therapeutics

HemOnc Today, January 10, 2019
Patrick C. Ma, MD, MSc
On Nov. 26, the FDA announced the accelerated approval of larotrectinib as the first small molecule inhibitor for use in a “cancer-agnostic” manner, in…
In the Journals PlusPerspective

US cancer deaths down 27% in 25 years, but socioeconomic gaps widening

January 8, 2019
The overall rate of cancer deaths in the U.S. has declined by 27% during the past 25 years, with approximately 2.6 million fewer cancer deaths reported between 1991 and…
More Headlines »

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »

VIDEO: New data emerges for adjuvant treatment of melanoma

March 10, 2018
More »
Resource Centers